Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News and Events
iCAN science seminar on Bridging the radiology-pathology gap for prostate cancer characterization with Assist. Prof. Mirabela Rusu
Welcome to the iCAN science seminar with Assistant Professor Mirabela Rusu (Stanford University) on Bridging the radiology-pathology gap for prostate…
Doctoral Defense of Fernando Perez Villatoro: Tumor microenvironment and genomic biomarkers for precision oncology in high-grade serous ovarian cancer
You are warmly welcomed to the doctoral defense of Fernando Perez Villatoro. When: May 9th, 2025 at 13:00 Where: Biomedicum…
Miksi kliinisiä tutkimuksia tarvitaan Suomeen? -tilaisuus
Suomessa tehtävien kliinisten lääketutkimusten määrä on ollut laskussa jo yli 25 vuotta. Miksi kliinisiä tutkimuksia tarvitaan ja miten niitä saadaan…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding
